India bans exports of anti-viral drug Remdesivir as Covid-19 cases surgeNew Covid-19 cases in India surged to a record of 152,879 on Sunday as the country battled a second wave of infections by pushing for faster vaccinations.
India said on Sunday it had banned the export of anti-viral drug Remdesivir and its active pharmaceutical ingredients after a record spike in Covid-19 cases sent demand surging.
"In light of the above, Government of India has prohibited the exports of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the situation improves," the health ministry said in a statement.
Seven Indian companies have licensed the drug from Gilead Sciences, with an installed capacity of about 3.9 million units per month.
India leads the world in the daily average number of new infections reported, accounting for one in every six infections reported globally each day, according to a Reuters tally.
Deaths have also surged, with the federal health ministry reporting 839 fatalities on Sunday - the highest in over five months - as hospitals and crematoriums in some parts of the country grappled with the worsening situation.